iCarbonX

iCarbonX is focused on creating a comprehensive ecosystem of digital health by integrating consumers' life data with artificial intelligence and biotechnology. The company, founded by a team with extensive experience in omics technology and data analysis from BGI Tech, aims to establish a leading data collection platform for health information in China. By gathering a wide range of data—including genomic, phenotypic, behavioral, social, and environmental factors—iCarbonX provides personalized health analyses and predictions. Its platform is designed to empower individuals to understand their genetic profiles and make informed decisions about their health and well-being, leveraging advanced data mining and machine learning techniques.

Hao Li

Co-Founder and CIO

Jun Wang

Founder and CEO

Cindy Yang

Chief Investment Officer and Partner

9 past transactions

Reach Media

Series B in 2018
Shanghai Reach Media Co., Ltd. is an advertising services provider founded in 2014 and headquartered in Shanghai, China. The company specializes in creating advertising opportunities within medium to high-end communities. Its services include advertising bulletin boards that focus on cultural community activities and service-oriented information channels. This approach allows businesses to effectively promote their products and services while enabling communities to share important news and updates with residents. Through these targeted advertising solutions, Reach Media aims to connect companies with a broader consumer base.

SomaLogic

Private Equity Round in 2018
SomaLogic, Inc. is a commercial-stage company based in Boulder, Colorado, specializing in protein biomarker discovery and clinical diagnostics. Founded in 1999, the company has developed advanced technologies such as SOMAmers, slow off-rate modified aptamers that specifically bind to target proteins, and the SOMAscan platform, which facilitates comprehensive protein measurement. This innovative approach allows for the analysis of protein biomarker signatures, significantly enhancing the understanding of health and disease beyond traditional genomic methods. SomaLogic's products are utilized in a variety of applications, including diagnostics for conditions in oncology, neurology, and cardiovascular and metabolic diseases, as well as in drug discovery and development. The company also offers diagnostic tests and protein measurement solutions for life science and biopharma researchers, contributing to advancements in medical science.

HealthLoop

Series B in 2017
HealthLoop, Inc. is a healthcare technology company that offers a software-as-a-service (SaaS) platform designed to enhance patient engagement and support recovery processes. Founded in 2009 and headquartered in Moffett Field, California, the platform allows medical practices to monitor patient signs and symptoms while facilitating communication during recovery. By collecting feedback and tracking patient progress, HealthLoop helps doctors identify individuals at risk of complications, treatment failures, or hospital readmissions. The platform engages patients before their hospital admission and continues to guide them after discharge, thereby improving care coordination and ultimately aiming for better health outcomes. It primarily serves medical offices across the United States.

PatientsLikeMe

Venture Round in 2017
PatientsLikeMe, Inc. is a healthcare data-sharing platform founded in 2004 and based in Cambridge, Massachusetts. The company enables patients to share their symptoms, treatments, and health experiences, facilitating communication among patients, caregivers, physicians, researchers, and pharmaceutical companies. With over 600,000 members, it serves as a trusted source for real-world disease information across various health conditions, including cancer, mental health, and neurological disorders. PatientsLikeMe actively collaborates with major pharmaceutical companies and government organizations to integrate the patient perspective into research and public policy. The platform not only helps individuals find new treatment options and connect with others but also contributes to the development of new therapies through shared health data. The company has published more than 100 research studies, establishing itself as a clinically robust resource in the healthcare landscape. PatientsLikeMe is a subsidiary of United Healthcare Services, Inc.

PatientsLikeMe

Acquisition in 2017
PatientsLikeMe, Inc. is a healthcare data-sharing platform founded in 2004 and based in Cambridge, Massachusetts. The company enables patients to share their symptoms, treatments, and health experiences, facilitating communication among patients, caregivers, physicians, researchers, and pharmaceutical companies. With over 600,000 members, it serves as a trusted source for real-world disease information across various health conditions, including cancer, mental health, and neurological disorders. PatientsLikeMe actively collaborates with major pharmaceutical companies and government organizations to integrate the patient perspective into research and public policy. The platform not only helps individuals find new treatment options and connect with others but also contributes to the development of new therapies through shared health data. The company has published more than 100 research studies, establishing itself as a clinically robust resource in the healthcare landscape. PatientsLikeMe is a subsidiary of United Healthcare Services, Inc.

AOBiome

Series C in 2017
AOBiome, LLC is a biotechnology company based in Cambridge, Massachusetts, that specializes in developing microbiome-based therapies for the treatment of inflammatory skin conditions and other systemic ailments. The company is focused on restoring human health through its innovative products that utilize ammonia-oxidizing bacteria to balance the skin biome. AOBiome's portfolio includes several clinical-stage programs aimed at addressing various conditions, such as acne vulgaris, pediatric and adult eczema, episodic migraines, and allergic rhinitis. Its product candidates leverage a specific strain of auto-regulating ammonia-oxidizing bacteria, which are essential to human health. Additionally, AOBiome offers a consumer product line branded as Mother Dirt, aimed at maintaining skin health. Originally founded as NitroCell BioSciences LLC in 2012, the company rebranded to AOBiome in 2013.

Banruo Computer

Post in 2016
Banruo Computer is assisted at research and development with computing. They were committed to providing big data computing services and application solutions in the internet, telecommunications, and financial industries. They have obtained property protection through the use of software copyrights and invention patents for their big data ETL processing, mathematical modelling, and computing simulation skills, as well as a variety of technologies.

Imagu Vision Technologies

Acquisition in 2016
Imagu Vision Technologies Ltd. specializes in software solutions for object recognition in digital images and videos, utilizing advanced shape-based detection technology for geometric and topological analysis. Founded in 2005 and based in Tel-Aviv, Israel, the company applies its innovative technology across various industries, including healthcare, medical imaging, semiconductors, homeland security, and e-commerce. Imagu's software facilitates complex object detection and segmentation, allowing for customized applications tailored to specific user needs. Its technology addresses diverse challenges, such as defect detection in e-commerce images, human object detection in military contexts, and the segmentation of retinal blood vessels in medical imaging. By focusing on high-performance solutions and rapid deployment, Imagu Vision Technologies aims to enhance machine understanding of visual environments.

nongfadai.com

Series A in 2016
Nongfadai.com is a financial services platform for the agricultural supply chain. Their services for agriculture, rural areas, farmers, and meeting the funding gap in the development of modern agriculture.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.